Skip to main content
Jeffrey Bender, MD, Cardiology, New Haven, CT

Jeffrey Robert Bender MD

Preventive Cardiology


Robert I. Levy Prof. of Cardiology, Director Yale Cardiovascular Research Center, Assoc. Chief, Cardiovascular Medicine, Yale U. School. of Medicine

Join to view full profile
  • 800 Howard AveYale Physicians BuildingNew Haven, CT 06519

  • Phone+1 203-785-2140

Dr. Bender is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Stanford Health Care
    Stanford Health CarePost-Doctoral Fellowship, 1984 - 1988
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1983 - 1986
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterChief Residency, Internal Medicine, 1982 - 1983
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1979 - 1982
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1979

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1988 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • President Association of University Cardiologists, 2013
  • Elected member Association of American Physicians, 2002
  • Robert I. Levy Endowed Professorship Yale University, 2002

Publications & Presentations

PubMed

Grant Support

  • Vascular Training GrantYALE UNIVERSITY2000–2031
  • IL-17A mRNA-targeted oligonucleotide therapeutics in Idiopathic Pulmonary Fibrosis (IPF)TARGETSITE THERAPEUTICS CORPORATION2023–2025
  • Immune cell skewing with RNA target site oligonucleotides to promote vascular smooth muscle cell homeostasisYALE UNIVERSITY2022–2025
  • Vascular disease pathogenesis: interface between smooth muscle and immune cellsNIH2018–2023
  • Competitive Macrophage MicroRNA-RNA Binding Protein Interactions in Wound RepairNIH2017–2022

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: